journal article·2026-09-01Open access

Extruded droplet-on-demand (X-DoD) bioprinting for controlled iPSC-based functional cortical network formation

Elisabeth Riska, Roni Cohen, Lior Perry-Tomer, Yahel Shechter, Eric Silberman, Assaf Shapira, Tal Dvir

Biofabrication· Volume 18· Issue 3

Abstract

Abstract Engineered three-dimensional (3D) neural constructs hold significant promise for repairing neural tissue damage and recapitulating the human brain in vitro for disease modeling and drug screening applications. However, most current 3D neural models, including freestanding organoids and dense bioprinted neural constructs, lack the architectural and functional organization required to emulate the cerebral cortex, which comprises gray matter regions rich in neuronal cell bodies and white matter tracts formed by long-range axonal projections. This architectural mismatch limits the models’ ability to support functional connectivity analysis, predict in vivo behavior, and achieve effective integration with host tissue. In this study, we present an extruded droplet-on-demand (X-DoD) bioprinting technique that enables deterministic spatial patterning of droplets containing human induced pluripotent stem cells encapsulated within an extracellular matrix (ECM)-based hydrogel and embedded in a permissive, low-concentration hydrogel bulk that supports diffusion. Using a 5 × 5 droplet array pattern, we demonstrate that after 30 d of differentiation into cortical neurons and formation of 3D neuronal networks, the micron-scale, cell-body-dense droplets (microtissues) remain localized at their initial droplet sites and are interconnected by millimeter-scale neurite projections. This defined gray–white matter-like organization enables functional analysis via calcium imaging and seamless integration with custom electronic devices for advanced neurophysiological interrogation. Calcium imaging and electrical recordings revealed temporally preserved, propagating network activity, with network excitability dynamically modulated by treatment with GABA antagonist bicuculline. Altogether, the X-DoD bioprinting platform offers a powerful and adaptable approach for engineering spatially organized 3D neural networks with tunable connectivity, providing a robust tool for studying brain function, disease modeling, and future therapeutic applications.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Neuroscience and Neural Engineering · Pluripotent Stem Cells Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Tel Aviv University

The Center for Nanoscience and Nanotechnology, Tel Aviv University

Sagol Center for Regenerative Biotechnology, Tel Aviv University

Sagol School for Neuroscience, Tel Aviv University

References (68)

Show source-provided references
1. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the global burden of disease study 202110.1016/S1474-4422(24)00038-3 ↗
2. Global, regional, and national burden of neurological disorders in 204 countries and territories worldwide10.7189/jogh.13.04160 ↗
3. Recovery after brain injury: mechanisms and principles10.3389/fnhum.2013.00887 ↗
4. Measuring the thickness of the human cerebral cortex from magnetic resonance images10.1073/pnas.200033797 ↗
5. Physiology, cerebral cortex functions Statpearls
6. Advances in 3D tissue models for neural engineering: self-assembled versus engineered tissue models10.1039/D4BM00317A ↗
7. Induced pluripotent stem cells and their use in human models of disease and development10.1152/physrev.00039.2017 ↗
8. Tissue-engineered models of the human brain: state-of-the-art analysis and challenges10.3390/jfb13030146 ↗
9. Pluripotent stem cell based cultures to study key aspects of human cerebral cortex development
10. Modelling human brain development and disease with organoids10.1038/s41580-024-00804-1 ↗
11. Advances in 3D printing combined with tissue engineering for nerve regeneration and repair10.1186/s12951-024-03052-9 ↗
12. Recent advances in 3D bioprinted neural models: a systematic review on the applications to drug discovery10.1016/j.addr.2025.115524 ↗
13. 3D bioprinted neural tissues: emerging strategies for regeneration and disease modeling10.3390/pharmaceutics17091176 ↗
14. Human iPSC-derived spinal neural progenitors enhance sensorimotor recovery in spinal cord-injured NOD-SCID mice via differentiation and microenvironment regulation10.1038/s41419-025-07961-x ↗
15. Regenerating the injured spinal cord at the chronic phase by engineered iPSCs-derived 3D neuronal networks10.1002/advs.202105694 ↗
16. Progress in the use of induced pluripotent stem cell‐derived neural cells for traumatic spinal cord injuries in animal populations: meta‐analysis and review10.1002/sctm.18-0225 ↗
17. Human iPS cell-derived dopaminergic neurons function in a primate Parkinson’s disease model10.1038/nature23664 ↗
18. Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson’s disease10.1038/s41586-025-08700-0 ↗
19. 3D bioprinting in tissue engineering: advancements, challenges, and pathways to clinical translation10.47739/1023 ↗
20. 3D printing of personalized thick and perfusable cardiac patches and hearts10.1002/advs.201900344 ↗
21. Three-dimensional, multifunctional neural interfaces for cortical spheroids and engineered assembloids10.1126/sciadv.abf9153 ↗
22. Tissue engineering and regenerative medicine: history, progress, and challenges10.1146/annurev-chembioeng-061010-114257 ↗
23. The tissue engineering revolution: from bench research to clinical reality10.3390/biomedicines12020453 ↗
24. LIFT of cell spheroids: proof of concept10.1016/j.bprint.2023.e00297 ↗
25. Multi-compartmental biomaterial scaffolds for patterning neural tissue organoids in models of neurodevelopment and tissue regeneration10.1177/2041731416671926 ↗
26. 3D bioprinting of high cell-density heterogeneous tissue models through spheroid fusion within self-healing hydrogels10.1038/s41467-021-21029-2 ↗
27. Maturation and circuit integration of transplanted human cortical organoids10.1038/s41586-022-05277-w ↗
28. Integration of 3D-printed cerebral cortical tissue into an ex vivo lesioned brain slice10.1038/s41467-023-41356-w ↗
29. 3D bioprinting of human neural tissues with functional connectivity10.1016/j.stem.2023.12.009 ↗
30. Three‐dimensional functional neuronal networks in free‐standing bioprinted hydrogel constructs10.1002/adhm.202300801 ↗
31. Advanced 3D models of human brain tissue using neural cell lines: state-of-the-art and future prospects10.3390/cells12081181 ↗
32. A microfluidic culture platform for CNS axonal injury, regeneration and transport—PMC10.1038/nmeth777 ↗
33. Compartmentalized microfluidic platforms: the unrivaled breakthrough of in vitro tools for neurobiological research10.1523/JNEUROSCI.1748-16.2016 ↗
34. Modulation of neural network activity by patterning10.1016/S0956-5663(01)00166-X ↗
35. Annals of 3D printed medicine could 3D extrusion bioprinting serve to be a real alternative to organ transplantation in the future ?10.1016/j.stlm.2022.100066 ↗
36. Bioprinting for the Biologist10.1016/j.cell.2020.12.002 ↗
37. Three dimensional bioprinting of neural tissues10.1002/adhm.202001600 ↗
38. One-step 3D printing of heart patches with built-in electronics for performance regulation10.1002/advs.202004205 ↗
39. Personalized hydrogels for engineering diverse fully autologous tissue implants10.1002/adma.201803895 ↗
40. Modified ECM-based bioink for 3D printing of multi-scale vascular networks10.3390/gels9100792 ↗
41. Decellularization in tissue engineering and regenerative medicine: evaluation, modification, and application methods10.3389/fbioe.2022.805299 ↗
42. Decellularized extracellular matrix scaffolds: recent trends and emerging strategies in tissue engineering10.1016/j.bioactmat.2021.09.014 ↗
43. Decellularized extracellular matrix-based composite scaffolds for tissue engineering and regenerative medicine10.1093/rb/rbad107 ↗
44. A comprehensive review on 3D tissue models: biofabrication technologies and preclinical applications10.1016/j.biomaterials.2023.122408 ↗
45. Post-maturation reinforcement of 3d-printed vascularized cardiac tissues10.1002/adma.202302229 ↗
46. Injectable nanocomposite implants reduce ros accumulation and improve heart function after infarction10.1002/advs.202102919 ↗
47. A beginner’s guide to the characterization of hydrogel microarchitecture for cellular applications10.3390/gels8090535 ↗
48. Misleading pore size measurements in gelatin and alginate hydrogels revealed by confocal microscopy10.1089/ten.tec.2024.0117 ↗
49. A simple Ca 2 + -imaging approach to neural network analyses in cultured neurons10.1016/j.jneumeth.2020.109041 ↗
50. Combined small-molecule treatment accelerates maturation of human pluripotent stem cell-derived neurons10.1038/s41587-023-02031-z ↗
51. Functional characterization of three-dimensional cortical cultures for in vitro modeling of brain networks10.1016/j.isci.2020.101434 ↗
52. A stretchable and flexible cardiac tissue–electronics hybrid enabling multiple drug release, sensing, and stimulation10.1002/smll.201805526 ↗
53. iDISCO: a simple, rapid method to immunolabel large tissue samples for volume imaging10.1016/j.cell.2014.10.010 ↗
54. Omentum a powerful biological source in regenerative surgery10.1016/j.reth.2019.07.008 ↗
55. Optimizing the biofabrication process of omentum-based scaffolds for engineering autologous tissues10.1088/1758-5082/6/3/035023 ↗
56. Engineered assistive materials for 3D bioprinting: support baths and sacrificial inks10.1088/1758-5090/ac6bbe ↗
57. An overview of extracellular matrix-based bioinks for 3D bioprinting10.3389/fbioe.2022.905438 ↗
58. Evaluation of a standardised procedure to assess the shape of pellets using image analysis10.1016/S0378-5173(99)00302-6 ↗
59. Evaluation of alginate-based bioinks for 3d bioprinting, mesenchymal stromal cell osteogenesis, and application for patient-specific bone grafts10.1089/ten.tea.2020.0305 ↗
60. Live/dead quantification using fiji—step-by-step guide | support—allevi
61. Neural induction—dual SMAD inhibition StemBook
62. Chapter 23—Animal models of stroke versus clinical stroke: comparison of infarct size, cause, location, study design, and efficacy of experimental therapies10.1016/B978-0-12-415894-8.00023-3 ↗
63. Brain networks and their relevance for stroke rehabilitation10.1016/j.clinph.2019.04.004 ↗
64. Barrel cortex plasticity after photothrombotic stroke involves potentiating responses of pre-existing circuits but not functional remapping to new circuits10.1038/s41467-021-24211-8 ↗
65. In vivo calcium imaging reveals functional rewiring of single somatosensory neurons after stroke10.1523/JNEUROSCI.0622-08.2008 ↗
66. In vivo voltage-sensitive dye imaging in adult mice reveals that somatosensory maps lost to stroke are replaced over weeks by new structural and functional circuits with prolonged modes of activation within both the peri-infarct zone and distant sites10.1523/JNEUROSCI.4249-08.2009 ↗
67. Displacement of sensory maps and disorganization of motor cortex after targeted stroke in mice10.1161/STROKEAHA.113.001272 ↗
68. Mesenchymal stem cell spheroids embedded in an injectable thermosensitive hydrogel: an in situ drug formation platform for accelerated wound healing10.1021/acsbiomaterials.0c00988 ↗